|Articles|June 22, 2009
FDA's Keith Webber on Setting Specifications
Author(s)BioPharm International Editors
Advertisement
FDA´s Keith Webber on Setting Specifications
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
2
FAQ: What You Need to Know About Agentic AI in Drug Discovery
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
5